Creso Pharma has signed a distribution agreement with nutritional supplements company Route2 Pharm for the distribution of its cannaQix 10, Cannaqix 50 and CannaDOL product lines in Pakistan, the Philippines and other emerging markets.
The agreement follows a landmark decision by the Pakistan Government allowing the country to enter the cannabidiol market. Pakistan has a population of more than 216 million people and a wide range of unmet needs.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.